Company, Human health, Animal health
We are pleased to announce that our core patent covering the isolation of stem cells from muscular microbiopsies has been officially granted in Chile.
This patent extends the territorial protection of Revatis' proprietary technology to Latin America and supports the company's long-term str
ategy to build value through a robust international IP portfolio. The decision to seek protection in Chile reflects the increasing scientific and commercial interest in regenerative medicine across the region.
The granted patent covers applications across species, including human and veterinary use, and reinforces Revatis' commitment to advancing innovative and minimally invasive solutions in cell-based therapies.
#stemcells #cellandgenetherapy #regenerativemedicine #IP #innovation #researchanddevelopment